Answer
Whether eptacog beta (Cevenfacta) passes into human breast milk is unknown, and a decision must be made whether to discontinue breast-feeding or discontinue/abstain from Cevenfacta therapy, considering the benefits of breast-feeding for the child and treatment for the woman.
Sources for this answer
- CEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injectionLFB Biopharmaceuticals Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked